Lucid Group

About:

Lucid aims to develop a unique 3 in one diagnostic device.

Website: http://www.lucidinnovation.com

Twitter/X: lucidinnovation

Top Investors: SBRI Healthcare

Description:

Lucid aims to develop a unique 3 in one diagnostic device. The device would help intuitive, fast and economic measure biophysiological markers (pressure, sensation and muscle contractility – via EMG), enabling more precise diagnosis of the functional deficits in faecal incontinence at primary care.

Total Funding Amount:

917000 GBP

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Manchester, Manchester, United Kingdom

Founded Date:

2002-01-01

Contact Email:

ideas(AT)lucidinnovation.com

Founders:

Alistair Williamson

Number of Employees:

11-50

Last Funding Date:

2015-02-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai